Unapproved synthetic peptides see demand explode on gray market

7 articles · Updated · The Wall Street Journal · May 7

Online wellness hype is driving interest in injections promoted for muscle gains, clearer skin and healthier hair, despite lacking approval.
The report says some peptides are used in FDA-approved medicines, including GLP-1 drugs, but unapproved versions carry potential risks.
The surge highlights a fast-growing gray market for wellness products as consumers seek performance and cosmetic benefits beyond regulated treatments.

With the FDA easing peptide rules, are athletes facing a new era of career-ending doping risks from 'legal' wellness products?

The US is fast-tracking experimental peptides. Are we sacrificing safety science for the promises of online wellness influencers?